SPX3,785.38-33.45 -0.88%
DIA307.82-2.23 -0.72%
IXIC11,028.74-149.16 -1.33%

BRIEF-Spectrum Pharmaceuticals - On June 7, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

reuters.com · 06/10/2022 17:01
BRIEF-Spectrum Pharmaceuticals - On June 7, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

- Spectrum Pharmaceuticals Inc SPPI:

  • SPECTRUM PHARMACEUTICALS INC - ON JUNE 7, RECEIVED NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ


Further company coverage: SPPI


((Reuters.Briefs@thomsonreuters.com;))